Correlation Between Molecular Partners and Inhibrx
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Inhibrx, you can compare the effects of market volatilities on Molecular Partners and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Inhibrx.
Diversification Opportunities for Molecular Partners and Inhibrx
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Molecular and Inhibrx is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Molecular Partners i.e., Molecular Partners and Inhibrx go up and down completely randomly.
Pair Corralation between Molecular Partners and Inhibrx
Given the investment horizon of 90 days Molecular Partners AG is expected to generate 1.2 times more return on investment than Inhibrx. However, Molecular Partners is 1.2 times more volatile than Inhibrx. It trades about 0.02 of its potential returns per unit of risk. Inhibrx is currently generating about 0.0 per unit of risk. If you would invest 670.00 in Molecular Partners AG on September 2, 2024 and sell it today you would lose (88.00) from holding Molecular Partners AG or give up 13.13% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. Inhibrx
Performance |
| Timeline |
| Molecular Partners |
| Inhibrx |
Molecular Partners and Inhibrx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Inhibrx
The main advantage of trading using opposite Molecular Partners and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.| Molecular Partners vs. Tff Pharmaceuticals | Molecular Partners vs. Eliem Therapeutics | Molecular Partners vs. Inhibrx | Molecular Partners vs. Enliven Therapeutics |
| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |